The United States banking sector had been in the spotlight in the first half of last year, as a series of events shook the industry and the markets. In March 2023, a wave of bond selloffs triggered...

With the recent uptrend in large-cap stocks, as reflected by the performance of the SPDR S&P 500 ETF Trust NYSEARCA: SPY, many stocks with top revenue and earnings growth rates are flashing bullish...

As the year came to a close in 2023, the market edged toward its all-time high, with the SPDR S&P 500 ETF Trust NYSE: SPY trading at its 52-week high. Previously beaten-down stocks with a high shor...

George Ball, chairman at Sanders Morris Harris, joins 'Power Lunch' to discuss Ball's investment take on three stocks: Affirm Holdings, Gilead Sciences, and 3M.

Buy now, pay later helped fuel record holiday spending online in 2023, but now that those bills are coming due, consumers aren't sure how they'll pay them.

Many stocks had incredible runs in 2023, and not just the so called “Magnificent 7” mega-cap technology concerns. While underreported, many stocks beat the performance of the Magnificent 7 last year.

Investors interested in Business - Services stocks are likely familiar with Rentokil Initial PLC (RTO) and Affirm Holdings (AFRM). But which of these two stocks presents investors with the better v...

After riding a nine-week win streak to $52.48 on December 27, Affirm shares closed at $41.79 on Friday as traders continued to take profits — one of the early winter's biggest gainers.

Affirm (AFRM) is poised for long-term growth driven by improving gross merchandise value, active merchants and transactions.

Affirm (AFRM) collaborates with Evolve to provide flexible payment options to qualifying travelers, thereby improving the travel experience.

Financial technology can help transform an economy and it has emerged as a strong sector in 2023. The industry did face some volatility throughout the year, but with inflation easing, it looks like...

SoFi Technologies is rapidly growing with digital banking. Affirm is threatening the credit card industry.

The start of a new year is the time to take a look at your portfolio and make the necessary changes. While it may not be possible for you to sell stocks unless you are making a profit on them, it c...

Among 2023 IPOs, one of the top performers was RayzeBio Inc. NASDAQ: RYZB, a biotech that's out of play now because it's being acquired by Bristol Myers Squibb Co. NYSE: BMY.

In the ever-shifting terrain of the financial sector, fintech stocks have emerged as both a turbulent and transformative force. These stocks, imperative in the digital overhauling of financial syst...